Aurinia Pharmaceuticals Inc (AUPH)
Healthcare
Biotechnology
14.90 $
-0.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Aurinia Pharmaceuticals Inc (AUPH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.2% of the shares are freely tradable; institutional investors hold 60.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
60.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
7.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
98.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
129Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 9.51 | 12,229,500 | +7.9 | 03/31/2026 |
| BlackRock Inc | 6.10 | 7,845,521 | -1.0 | 03/31/2026 |
| NEA Management Company, LLC | 3.09 | 3,969,834 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 2.67 | 3,428,705 | +74.7 | 03/31/2026 |
| Arrowstreet Capital Limited Partnership | 2.55 | 3,284,368 | -3.0 | 03/31/2026 |
| State Street Corp | 1.97 | 2,527,099 | +1.0 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 1.74 | 2,232,548 | +0.7 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 1.46 | 1,874,597 | +19.0 | 03/31/2026 |
| Renaissance Technologies Corp | 1.29 | 1,663,835 | +4.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Russell 2000 ETF | 2.22 | 2,853,852 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.